Who Paid My Doc
Samuel Pabon Rivera
Pediatric Hematology-Oncology San Antonio, TX Medical Doctor
NPI 1194269555 CMS profile 3642240
4502 Medical Dr, San Antonio, TX 78229
General payments
$23,054
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Samuel Pabon Rivera of San Antonio, TX is reported in the CMS Open Payments database as having received $23,054 across 71 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 85th percentile of Pediatric Hematology-Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $15,501 | 37 | |
| 2024 | General | $5,991 | 17 | |
| 2023 | General | $445 | 5 | |
| 2022 | General | $520 | 5 | |
| 2021 | General | $348 | 4 | |
| 2019 | General | $249 | 3 |
Beside peers
- Samuel Pabon Rivera
- Pediatric Hematology-Oncology median
- Middle half of Pediatric Hematology-Oncology
- National median
In program year 2025, general payments to Samuel Pabon Rivera were reported at $15,501. Among 1,352 Pediatric Hematology-Oncology profiles paid that year, the median was $204 and the middle half received between $80 and $2,819.
Show as a table
| Year | Samuel Pabon Rivera | Pediatric Hematology-Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $249 | $184 | $69–$2,094 | $163 |
| 2020 | $0 | $220 | $37–$3,941 | $114 |
| 2021 | $348 | $366 | $63–$4,909 | $132 |
| 2022 | $520 | $181 | $66–$2,775 | $149 |
| 2023 | $445 | $175 | $62–$2,600 | $160 |
| 2024 | $5,991 | $227 | $66–$2,992 | $164 |
| 2025 | $15,501 | $204 | $80–$2,819 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
71 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Hematology-Oncology in Texas
Stanton Goldman
Pediatric Hematology-Oncology · Dallas, TX
Vivek Subbiah
Pediatric Hematology-Oncology · Houston, TX
Maurizio Ghisoli
Pediatric Hematology-Oncology · Dallas, TX
Anish Ray
Pediatric Hematology-Oncology · Fort Worth, TX
Joel Weinthal
Pediatric Hematology-Oncology · Dallas, TX
Prasad Mathew
Pediatric Hematology-Oncology · El Paso, TX
Related records
Pediatric Hematology-Oncology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Hematology-Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.